Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007427045> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2007427045 endingPage "238" @default.
- W2007427045 startingPage "233" @default.
- W2007427045 abstract "Pain management is central in the care of patients in paediatric oncology. Intravenous (i.v.) morphine infusion is an important treatment modality. The objectives of this study were to identify the characteristics of children who receive i.v. morphine infusions in a paediatric oncology setting and to describe the effectiveness, tolerability, and limiting side-effects of this treatment.We prospectively collected evaluation charts for all morphine infusions in a paediatric oncology unit during a 4-year period, and reviewed the medical records of the patients. The incidence of breakthrough pain was used as a measure of the effectiveness of morphine treatment. For comparison, patients were grouped according to causes of pain; minor surgery, major surgery, tumour/disease, or treatment side-effects.Overall, 72 individuals (36% of all 201 patients diagnosed in the unit) were given morphine infusions. Patients with pain after major surgery suffered from more breakthrough pain than the other patients during the 1st day of morphine treatment even though their morphine consumption was almost twice as high (0.64 vs. 0.36 mg/kg, P < 0.001); 92% of these patients had solid tumours. Common morphine side-effects were vomiting (38%), nausea (32%), and constipation (24%).Patients who undergo major tumour surgery require extensive pain management to achieve acceptable post-operative pain relief. The routine of giving both a bolus dose and increasing the morphine dose at breakthrough pain should be encouraged. For the other patients studied, morphine infusions were considered to be adequate, but vomiting, nausea, and constipation might be reduced if prophylactic antiemetics and laxatives were given." @default.
- W2007427045 created "2016-06-24" @default.
- W2007427045 creator A5010485163 @default.
- W2007427045 creator A5063765068 @default.
- W2007427045 date "2003-01-27" @default.
- W2007427045 modified "2023-09-25" @default.
- W2007427045 title "Characteristics and adequacy of intravenous morphine infusions in children in a paediatric oncology setting" @default.
- W2007427045 cites W127972426 @default.
- W2007427045 cites W1745810113 @default.
- W2007427045 cites W1967170227 @default.
- W2007427045 cites W1969694692 @default.
- W2007427045 cites W1989106853 @default.
- W2007427045 cites W2000942099 @default.
- W2007427045 cites W2007797408 @default.
- W2007427045 cites W2024281266 @default.
- W2007427045 cites W2039291682 @default.
- W2007427045 cites W2046286165 @default.
- W2007427045 cites W2122484257 @default.
- W2007427045 cites W2234596741 @default.
- W2007427045 cites W2338599327 @default.
- W2007427045 cites W4242270309 @default.
- W2007427045 cites W4247782603 @default.
- W2007427045 doi "https://doi.org/10.1002/mpo.10254" @default.
- W2007427045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12555251" @default.
- W2007427045 hasPublicationYear "2003" @default.
- W2007427045 type Work @default.
- W2007427045 sameAs 2007427045 @default.
- W2007427045 citedByCount "14" @default.
- W2007427045 countsByYear W20074270452014 @default.
- W2007427045 countsByYear W20074270452017 @default.
- W2007427045 countsByYear W20074270452018 @default.
- W2007427045 countsByYear W20074270452020 @default.
- W2007427045 countsByYear W20074270452021 @default.
- W2007427045 crossrefType "journal-article" @default.
- W2007427045 hasAuthorship W2007427045A5010485163 @default.
- W2007427045 hasAuthorship W2007427045A5063765068 @default.
- W2007427045 hasConcept C126322002 @default.
- W2007427045 hasConcept C141071460 @default.
- W2007427045 hasConcept C197934379 @default.
- W2007427045 hasConcept C2777389121 @default.
- W2007427045 hasConcept C2778375690 @default.
- W2007427045 hasConcept C2780580376 @default.
- W2007427045 hasConcept C2780852908 @default.
- W2007427045 hasConcept C2781112942 @default.
- W2007427045 hasConcept C42219234 @default.
- W2007427045 hasConcept C43376680 @default.
- W2007427045 hasConcept C71924100 @default.
- W2007427045 hasConceptScore W2007427045C126322002 @default.
- W2007427045 hasConceptScore W2007427045C141071460 @default.
- W2007427045 hasConceptScore W2007427045C197934379 @default.
- W2007427045 hasConceptScore W2007427045C2777389121 @default.
- W2007427045 hasConceptScore W2007427045C2778375690 @default.
- W2007427045 hasConceptScore W2007427045C2780580376 @default.
- W2007427045 hasConceptScore W2007427045C2780852908 @default.
- W2007427045 hasConceptScore W2007427045C2781112942 @default.
- W2007427045 hasConceptScore W2007427045C42219234 @default.
- W2007427045 hasConceptScore W2007427045C43376680 @default.
- W2007427045 hasConceptScore W2007427045C71924100 @default.
- W2007427045 hasIssue "4" @default.
- W2007427045 hasLocation W20074270451 @default.
- W2007427045 hasLocation W20074270452 @default.
- W2007427045 hasOpenAccess W2007427045 @default.
- W2007427045 hasPrimaryLocation W20074270451 @default.
- W2007427045 hasRelatedWork W2035517983 @default.
- W2007427045 hasRelatedWork W2070683333 @default.
- W2007427045 hasRelatedWork W2131415019 @default.
- W2007427045 hasRelatedWork W2229196813 @default.
- W2007427045 hasRelatedWork W2349236515 @default.
- W2007427045 hasRelatedWork W2372024866 @default.
- W2007427045 hasRelatedWork W2406955521 @default.
- W2007427045 hasRelatedWork W2772112079 @default.
- W2007427045 hasRelatedWork W2901497709 @default.
- W2007427045 hasRelatedWork W4235011874 @default.
- W2007427045 hasVolume "40" @default.
- W2007427045 isParatext "false" @default.
- W2007427045 isRetracted "false" @default.
- W2007427045 magId "2007427045" @default.
- W2007427045 workType "article" @default.